AJP - Endocrinology and Metabolism, Vol 263, Issue 1 E173-E179, Copyright © 1992 by American Physiological Society

ARTICLES

Plasma leucine kinetics and urinary nitrogen excretion in intensively treated diabetes mellitus

F. Lariviere, D. B. Kupranycz, J. L. Chiasson and L. J. Hoffer
McGill Nutrition and Food Science Centre, McGill University, Montreal, Quebec, Canada.

It is well known that inadequate insulin therapy stimulates body protein loss in insulin-dependent diabetes mellitus (IDDM). It is less well known, however, that accelerated body protein loss (as indicated by increased leucine oxidation) occurs in IDDM even during conventional glycemic control. It is not known whether intensified insulin therapy fully normalizes protein oxidation or, more importantly, whether such therapy is sufficient to allow the adaptive decrease of protein oxidation that normally occurs when protein intake is restricted below the customary surfeit level. We used two measures of protein oxidation [daily urinary nitrogen (N) excretion over several days of intensive insulin therapy and plasma [1-13C]leucine oxidation during short-term strict euglycemia] to assess the response of 7 men with IDDM and 12 normal men after adaptation first to a control diet providing maintenance energy and conventional (surfeit) protein then to an isoenergetic protein-free diet. After adaptation to the protein-free diet and during short-term strict euglycemia achieved using intravenous insulin, leucine turnover and oxidation decreased equivalently in normal and diabetic subjects. However, daily urinary obligatory N excretion, which indicated the effect of the low-protein diet and intensive subcutaneous insulin therapy over several days, was increased by 18% in the diabetic group (P less than 0.05). Even mildly elevated average blood glucose values well within the guidelines for intensive therapy were strongly correlated with high rates of urinary N excretion (r = 0.97, P = 0.0002). Thus insulin therapy of IDDM that imposes strict euglycemia is compatible with a normal ability to diminish body protein oxidation in response to protein restriction.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. J. Hamadeh and L. J. Hoffer Effect of protein restriction on sulfur amino acid catabolism in insulin-dependent diabetes mellitus Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E382 - E389. [Abstract] [Full Text] [PDF]

				W. Kriengsinyos, M. Rafii, L. J. Wykes, R. O. Ball, and P. B. Pencharz Long-Term Effects of Histidine Depletion on Whole-Body Protein Metabolism in Healthy Adults J. Nutr., November 1, 2002; 132(11): 3340 - 3348. [Abstract] [Full Text] [PDF]

				M. J. Hamadeh, A. Schiffrin, and L. J. Hoffer Sulfate production depicts fed-state adaptation to protein restriction in humans Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E341 - E348. [Abstract] [Full Text] [PDF]

				P. G. Whittaker, C. H. Lee, and R. Taylor Whole body protein kinetics in women: effect of pregnancy and IDDM during anabolic stimulation Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E978 - E988. [Abstract] [Full Text] [PDF]

				Y. B. Lombardo, C. Serdikoff, M. Thamotharan, H. S. Paul, and S. A. Adibi Inverse alterations of BCKA dehydrogenase activity in cardiac and skeletal muscles of diabetic rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E685 - E692. [Abstract] [Full Text] [PDF]

				L. J. Hoffer Adaptation to Protein Restriction Is Impaired in Insulin-Dependent Diabetes Mellitus J. Nutr., February 1, 1998; 128(2): 333 - 333. [Abstract] [Full Text]